↓ Skip to main content

Risperidone dose for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, October 2009
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
7 tweeters

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
86 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Risperidone dose for schizophrenia
Published in
Cochrane database of systematic reviews, October 2009
DOI 10.1002/14651858.cd007474.pub2
Pubmed ID
Authors

Chunbo Li, Jun Xia, Jijun Wang

Abstract

Risperidone is a widely used antipsychotic drug for people with schizophrenia. It is important to get a balance between gaining the most positive effects for the least negative outcomes. The optimal dose of risperidone is the focus of this review.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Unknown 85 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 17%
Student > Master 13 15%
Student > Ph. D. Student 12 14%
Student > Doctoral Student 7 8%
Other 6 7%
Other 15 17%
Unknown 18 21%
Readers by discipline Count As %
Medicine and Dentistry 21 24%
Psychology 11 13%
Pharmacology, Toxicology and Pharmaceutical Science 10 12%
Nursing and Health Professions 9 10%
Business, Management and Accounting 3 3%
Other 11 13%
Unknown 21 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2016.
All research outputs
#8,438,396
of 16,381,314 outputs
Outputs from Cochrane database of systematic reviews
#8,617
of 11,494 outputs
Outputs of similar age
#58,590
of 128,783 outputs
Outputs of similar age from Cochrane database of systematic reviews
#71
of 104 outputs
Altmetric has tracked 16,381,314 research outputs across all sources so far. This one is in the 48th percentile – i.e., 48% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,494 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.2. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 128,783 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 104 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.